Healthcare Expenditures for the Treatment of Patients Infected with Hepatitis C Virus in Japan-Reference-Cited by-同舟云学术

Healthcare Expenditures for the Treatment of Patients Infected with Hepatitis C Virus in Japan

Published:2019-11-25 Issue:3 Volume:38 Page:297-306
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Fukuda Haruhisa^ORCID,Yano Yoshihiko,Sato Daisuke,Ohde Sachiko,Noto Shinichi,Watanabe Ryo,Takahashi Osamu

Funder

Ministry of Health, Labour and Welfare

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40273-019-00861-x.pdf

Reference35 articles.

1. Ministry of Health, Labour and Welfare. Estimates of national medical care expenditure 2015. http://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/15/dl/kekka.pdf. Accessed 19 Sept 2019.

2. Ministry of Health, Labour and Welfare. Trends in medical care expenditure FY2016. http://www.mhlw.go.jp/topics/medias/year/16/dl/iryouhi_data.pdf. Accessed 19 Sept 2019.

3. Ministry of Health, Labour and Welfare. NDB Open Data Japan 2014. http://www.mhlw.go.jp/seisakunitsuite/bunya/0000139390.html. Accessed 19 Sept 2019.

4. Ministry of Health, Labour and Welfare. NDB Open Data Japan 2015. http://www.mhlw.go.jp/seisakunitsuite/bunya/0000177221.html. Accessed 19 Sept 2019.

5. Kumada H, Suzuki Y, Ikeda K, et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology. 2014;59(6):2083–91.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world economic burden of hepatitis C and impact of direct‐acting antivirals in France: A nationwide claims data analysis;Liver International;2024-02-20

2. Does improvement in the environmental sustainability rating help to reduce the COVID-19 cases? Controlling financial development, price level and carbon damages;Environmental Science and Pollution Research;2021-05-03

3. Healthcare expenditure for HCV increases with age and stage;PharmacoEconomics & Outcomes News;2019-11